NCT02629354View on ClinicalTrials.gov

To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Healthy
Interventions
DRUG

Ibuprofen

DRUG

Caffeine

DRUG

Ibuprofen

Trial Locations (1)

Unknown

Boehringer Ingelheim Investigational Site, Bloemfontein

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02629354 - To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet | Biotech Hunter | Biotech Hunter